Literature DB >> 7099196

Quantitation of muscle function in children: a prospective study in Duchenne muscular dystrophy.

O M Scott, S A Hyde, C Goddard, V Dubowitz.   

Abstract

A protocol has been developed for the quantitative assessment of muscle function in children with muscle disease. It includes total muscle strength (% MRC) based on a clinical assessment of strength of 32 groups using the 6-point MRC grading; the force of 8 selected muscle groups measured with a specially designed electromyometer; a motor ability score based on 20 consecutive motor activities; walking times over 28 and 150 feet, and recording of muscle contractures. A 3-year sequential study of 61 boys with Duchenne dystrophy showed progressive decline of muscle strength with age, a close correlation of total strength and the motor ability score (r = 0.89), and a curvilinear relationship of muscle strength with walking times over 28 and 150 feet (r = 0.78 and 0.79, respectively). A profile of the natural progression of Duchenne dystrophy has been established which could serve as a reference base for the assessment of cases at varying ages and their response to therapy and management.

Entities:  

Mesh:

Year:  1982        PMID: 7099196     DOI: 10.1002/mus.880050405

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  50 in total

1.  Effects of rituximab in two patients with dysferlin-deficient muscular dystrophy.

Authors:  Alberto Lerario; Filippo Cogiamanian; Chiara Marchesi; Marzia Belicchi; Nereo Bresolin; Laura Porretti; Yvan Torrente
Journal:  BMC Musculoskelet Disord       Date:  2010-07-11       Impact factor: 2.362

2.  Muscle fat-fraction and mapping in Duchenne muscular dystrophy: evaluation of disease distribution and correlation with clinical assessments. Preliminary experience.

Authors:  Michele Gaeta; Sonia Messina; Achille Mileto; Gian Luca Vita; Giorgio Ascenti; Sergio Vinci; Antonio Bottari; Giuseppe Vita; Nicola Settineri; Daniele Bruschetta; Sergio Racchiusa; Fabio Minutoli
Journal:  Skeletal Radiol       Date:  2011-11-10       Impact factor: 2.199

3.  A modified Hammersmith functional motor scale for use in multi-center research on spinal muscular atrophy.

Authors:  Kristin J Krosschell; Jo Anne Maczulski; Thomas O Crawford; Charles Scott; Kathryn J Swoboda
Journal:  Neuromuscul Disord       Date:  2006-06-05       Impact factor: 4.296

4.  Computer-assisted hand-held dynamometer: low-cost instrument for muscle function assessment in rehabilitation medicine.

Authors:  J Harlaar; M E Roebroeck; G J Lankhorst
Journal:  Med Biol Eng Comput       Date:  1996-09       Impact factor: 2.602

5.  A novel trial design to study the effect of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  N Thompson; P Choudhary; R A Hughes; R M Quinlivan
Journal:  J Neurol       Date:  1996-03       Impact factor: 4.849

Review 6.  Prevention and management of limb contractures in neuromuscular diseases.

Authors:  Andrew J Skalsky; Craig M McDonald
Journal:  Phys Med Rehabil Clin N Am       Date:  2012-08       Impact factor: 1.784

7.  Age-related differences in lower-limb muscle cross-sectional area and torque production in boys with Duchenne muscular dystrophy.

Authors:  Sunita Mathur; Donovan J Lott; Claudia Senesac; Sean A Germain; Ravneet S Vohra; H Lee Sweeney; Glenn A Walter; Krista Vandenborne
Journal:  Arch Phys Med Rehabil       Date:  2010-07       Impact factor: 3.966

8.  MRI findings, patterns of disease distribution, and muscle fat fraction calculation in five patients with Charcot-Marie-Tooth type 2 F disease.

Authors:  Michele Gaeta; Achille Mileto; Anna Mazzeo; Fabio Minutoli; Rita Di Leo; Nicola Settineri; Rocco Donato; Giorgio Ascenti; Alfredo Blandino
Journal:  Skeletal Radiol       Date:  2011-05-25       Impact factor: 2.199

9.  Laboratory testing of muscle function in the management of neuromuscular disease.

Authors:  C M Wiles; Y Karni; J Nicklin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-05       Impact factor: 10.154

10.  Exon 45 skipping through U1-snRNA antisense molecules recovers the Dys-nNOS pathway and muscle differentiation in human DMD myoblasts.

Authors:  Valentina Cazzella; Julie Martone; Chiara Pinnarò; Tiziana Santini; Shyam Sundar Twayana; Olga Sthandier; Adele D'Amico; Valeria Ricotti; Enrico Bertini; Francesco Muntoni; Irene Bozzoni
Journal:  Mol Ther       Date:  2012-09-11       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.